Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Vano YA, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B, Barthélémy P, Coquan E, Gravis G, Houede N, Cancel M, Huillard O, Beuzeboc P, Fournier L, Méjean A, Cathelineau X, Doumerc N, Paparel P, Bernhard JC, de la Taille A, Bensalah K, Tricard T, Waeckel T, Pignot G, Braychenko E, Caruso S, Sun CM, Verkarre V, Lacroix G, Moreira M, Meylan M, Bougouïn A, Phan L, Thibault-Carpentier C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C, Oudard S. Vano YA, et al. Among authors: paparel p. Lancet Oncol. 2022 May;23(5):612-624. doi: 10.1016/S1470-2045(22)00128-0. Epub 2022 Apr 4. Lancet Oncol. 2022. PMID: 35390339 Clinical Trial.
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ; Comité de Transplantation de l'Association Française d'Urologie; Comité de Cancérologie de l'Association Française d'Urologie. Neuzillet Y, et al. Among authors: paparel p. Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2. Eur Urol. 2011. PMID: 21377780
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
Bigot P, Fardoun T, Bernhard JC, Xylinas E, Berger J, Rouprêt M, Beauval JB, Lagabrielle S, Lebdai S, Ammi M, Baumert H, Escudier B, Grenier N, Hétet JF, Long JA, Paparel P, Rioux-Leclercq N, Soulié M, Azzouzi AR, Bensalah K, Patard JJ. Bigot P, et al. Among authors: paparel p. World J Urol. 2014 Feb;32(1):109-14. doi: 10.1007/s00345-013-1088-1. Epub 2013 Apr 27. World J Urol. 2014. PMID: 23624719
Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study.
Paparel P, Bigot P, Matillon X, Bensalah K, Salomon L, Baumert H, Bastide C, Thuret R, Karsenty G, Long JA, Ammi M, Bessede T, Bin S, Roux A, Escudier B, Rioux Leclercq N, Pignot G, Soulie M, Patard JJ. Paparel P, et al. J Surg Oncol. 2014 Feb;109(2):126-31. doi: 10.1002/jso.23473. Epub 2013 Oct 30. J Surg Oncol. 2014. PMID: 24174430
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
Bigot P, Hétet JF, Bernhard JC, Fardoun T, Audenet F, Xylinas E, Ploussard G, Pignot G, Bessede T, Ouzaid I, Robine E, Brureau L, Merigot de Treigny O, Maurin C, Long JA, Rouffilange J, Hoarau N, Lebdai S, Rouprêt M, Bastien L, Neuzillet Y, Mongiat-Artus P, Verhoest G, Zerbib M, Ravery V, Rigaud J, Bellec L, Baumert H, Chautard D, Bensalah K, Escudier B, Paparel P, Grenier N, Rioux-Leclercq N, Azzouzi AR, Soulié M, Patard JJ. Bigot P, et al. Among authors: paparel p. Clin Genitourin Cancer. 2014 Feb;12(1):e19-27. doi: 10.1016/j.clgc.2013.09.004. Epub 2013 Sep 28. Clin Genitourin Cancer. 2014. PMID: 24210610
Safety and Feasibility of Laparoscopic Nephrectomy for Big Tumors (≥ 10 cm): A Retrospective Multicentric Study.
Verhoest G, Couapel JP, Oger E, Rioux-Leclercq N, Pignot G, Patard JJ, Bex A, Panayotopoulos P, Bigot P, Eret V, Hora M, Turna B, Lefevre M, Rigaud J, Tillou X, Doerfler A, Xylinas E, Soorojebally Y, Rouprêt M, Lagabrielle S, Bernhard JC, Long JA, Berger J, Ravier E, Paparel P, Salomon L, Rodriguez AR, Bensalah K. Verhoest G, et al. Among authors: paparel p. Clin Genitourin Cancer. 2016 Aug;14(4):e335-40. doi: 10.1016/j.clgc.2016.01.007. Epub 2016 Jan 27. Clin Genitourin Cancer. 2016. PMID: 26880025 Free article.
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA, Bernhard JC, Bigot P, Lanchon C, Paparel P, Rioux-Leclercq N, Albiges L, Bodin T, Nouhaud FX, Boissier R, Gimel P, Méjean A, Masson-Lecomte A, Grenier N, Cornelis F, Grassano Y, Comat V, Le Clerc QC, Rigaud J, Salomon L, Descotes JL, Sengel C, Roupret M, Verhoest G, Ouzaid I, Arnoux V, Bensalah K; French association of Urology Cancerology Comitee (CCAFU). Long JA, et al. Among authors: paparel p. World J Urol. 2017 Apr;35(4):649-656. doi: 10.1007/s00345-016-1913-4. Epub 2016 Aug 6. World J Urol. 2017. PMID: 27498139
Postoperative outcomes of elderly patients undergoing partial nephrectomy.
Ingels A, Duc S, Bensalah K, Bigot P, Paparel P, Beauval JB, Salomon L, De La Taille A, Lang H, Nouhaud FX, Batista Da Costa J, Dariane C, Baumert H, Roupret M, Waeckel T, Lebacle C, Long JA, Henon F, Patard JJ, Doumerc N, Mejean A, Videau MN, Bernhard JC. Ingels A, et al. Among authors: paparel p. Sci Rep. 2021 Aug 25;11(1):17201. doi: 10.1038/s41598-021-96676-y. Sci Rep. 2021. PMID: 34433877 Free PMC article. Clinical Trial.
Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82).
Tabourin T, Pinar U, Parra J, Vaessen C, Bensalah CK, Audenet F, Bigot P, Champy C, Olivier J, Bruyere F, Doumerc N, Paparel P, Parier B, Nouhaud FX, Durand X, Lang H, Branger N, Long JA, Durand M, Waeckel T, Charles T, Cussenot O, Xylinas E, Boissier R, Tambwe R, Patard JJ, Bernhard JC, Roupret M. Tabourin T, et al. Among authors: paparel p. Ann Surg Oncol. 2022 Oct;29(11):7218-7228. doi: 10.1245/s10434-022-12052-8. Epub 2022 Jul 3. Ann Surg Oncol. 2022. PMID: 35780452
[No title available]
[No authors listed] [No authors listed] PMID: 35989394
142 results